Add a description, image, and links to the casio-fx-991es-plus-calculator topic page so that developers can more easily learn about it.

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...